Reading Time: < 1 minute
Yesterday they did a presentation at Goldman Sachs 28th Annual conference (no web cast). Today they announced two new products getting FDA approval. The following picture is BC-3200, a hematology analyzer.
I don’t know the reason for Yesterday stock’s fall. Actually I placed a limited order at 28.02, and the price did drop to 28.02 at one point. But my order did not get filled. On the contrary, I remember once I sold Red Hat stock at a day’s lowest price. But again I sold HLYS at a day’s high price before its Q1 earning. So I am not complaining.